D-dimer is a marker of response to chemotherapy in patients with metastatic colorectal cancer. [electronic resource]
Producer: 20131119Description: 391-7 p. digitalISSN:- 1107-0625
- Aged
- Antigens, Tumor-Associated, Carbohydrate -- blood
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- CA-19-9 Antigen -- blood
- Capecitabine
- Carcinoembryonic Antigen -- blood
- Carcinoma -- blood
- Colorectal Neoplasms -- blood
- Deoxycytidine -- administration & dosage
- Female
- Fibrin Fibrinogen Degradation Products -- analysis
- Fluorouracil -- administration & dosage
- Humans
- L-Lactate Dehydrogenase -- blood
- Male
- Middle Aged
- Organoplatinum Compounds -- administration & dosage
- Oxaloacetates
- Proportional Hazards Models
- Time Factors
- Treatment Outcome
- Turkey
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.